[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370022-105":59,"doc-detail-370022-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hccs-serves-as-potential-prognostic-biomarker-and-therapeutic-target-in-human-breast-cancer-research-article","HCCS Serves as Potential Prognostic Biomarker and Therapeutic Target in Human Breast Cancer - Research Article","","Integrated bioinformatics analysis investigates holocytochrome c synthase (HCCS) as a candidate prognostic biomarker and therapeutic target across cancers with emphasis on breast cancer and triple-negative breast cancer. Public datasets and tools assess expression, promoter methylation, survival outcomes, immune infiltration, and interaction networks. Results show HCCS overexpression in breast cancer, linked to promoter hypomethylation and poorer relapse-free survival, alongside increased immune infiltration. Findings are validated in independent cohorts, supporting HCCS-driven mitochondrial and apoptotic pathways.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hccs-serves-as-potential-prognostic-biomarker-and-therapeutic-target-in-human-breast-cancer-research-article/370022/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hccs-serves-as-potential-prognostic-biomarker-and-therapeutic-target-in-human-breast-cancer-research-article/370022.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of this study on HCCS in breast cancer?","Question",{"text":112,"@type":113},"To examine HCCS expression profiles, epigenetic regulation, immune interactions, prognostic significance, and molecular networks, focusing on breast cancer and particularly triple-negative breast cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was HCCS expression and methylation analyzed in the study?",{"text":117,"@type":113},"The study used public datasets and bioinformatics tools to evaluate HCCS expression and promoter methylation patterns, including TCGA, UALCAN, and TNMplot.",{"name":119,"@type":110,"acceptedAnswer":120},"What key findings connect HCCS to breast cancer prognosis and immune infiltration?",{"text":121,"@type":113},"HCCS was overexpressed in breast cancer with the strongest increase in TNBC; promoter hypomethylation was associated with higher expression. High HCCS correlated with poorer relapse-free survival and greater immune infiltration across multiple immune cell types.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370022,1790218047,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Wiley  \nInternational Journal of Breast Cancer Volume 2025, Article ID 6717594, 27 pages [https://doi.org/10.1155/ijbc/6717594](https://doi.org/10.1155/ijbc/6717594)  \nResearch Article  \nHCCS Serves as Potential Prognostic Biomarker and Therapeutic Target in Human Breast Cancer  \nSm Faysal Bellah , 1,2 Md Alim Hossen ,3 S. M. Saker Billah ,4 and Md. Nur Islam 5  \n1Department of Pharmacy, Bangladesh University, Dhaka, Bangladesh  \n2Bangladesh University Research Center, Bangladesh University, Dhaka, Bangladesh  \n3Bioinformatics Laboratory, Department of Statistics, University of Rajshahi, Rajshahi, Bangladesh  \n4Department of Chemistry, National University, Gazipur, Bangladesh  \n5Department of Pharmacy, Manarat International University, Dhaka, Bangladesh  \nCorrespondence should be addressed to Sm Faysal Bellah; [faysal_phku@yahoo.com](faysal_phku@yahoo.com)  \nReceived 19 April 2025; Revised 2 October 2025; Accepted 14 October 2025  \nAcademic Editor: Ivana Ribeiro  \nCopyright © 2025 Sm Faysal Bellah et al. International Journal of Breast Cancer published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nBackground: Breast cancer is a leading cause of cancer-related morbidity and mortality in women worldwide. Among its subtypes, triple-negative breast cancer (TNBC) poses the greatest therapeutic challenge due to its aggressive nature and lack of targeted treatments. Holocytochrome c synthase (HCCS), a mitochondrial enzyme essential for cytochrome c maturation, may play a pivotal role in cancer pathogenesis.  \nObjective: This study aimed to investigate the expression proﬁle, epigenetic regulation, immune interactions, prognostic signiﬁcance, and molecular networks of HCCS across cancers, with a particular focus on breast cancer and its subtypes.  \nMethods: Publicly available datasets and bioinformatics tools were employed to analyze HCCS expression, methylation, survival outcomes, immune inﬁltration, and interaction networks. Expression and clinical outcomes were examined using TCGA, while methylation and expression patterns were assessed via UALCAN and TNMplot. Survival analyses were performed using Kaplan–Meier Plotter, and immune inﬁltration was evaluated with TIMER2.0 . Protein–protein interaction networks were generated with STRING, and functional enrichment was conducted through g:Proﬁler. Key ﬁndings were validated in independent breast cancer cohorts from GEO and the GOBO platform.  \nResults: HCCS was signiﬁcantly overexpressed in multiple cancers, with the highest upregulation observed in breast cancer, particularly TNBC. Hypomethylation of the HCCS promoter was associated with increased expression. High HCCS expression correlated with poorer relapse-free survival and greater immune inﬁltration, including CD4+ T cells, CD8+ T cells, macrophages (M1/M2), mast cells, and regulatory T cells. Protein–protein interaction analysis revealed HCCS-associated genes enriched in mitochondrial and apoptotic pathways. Validation across independent datasets consistently supported the association of elevated HCCS expression with poor prognosis in breast cancer.  \nConclusion: This integrated bioinformatics analysis highlights HCCS as a potential prognostic biomarker and therapeutic target in breast cancer, particularly in TNBC, although further experimental validation is required before clinical application.  \nKeywords: and TCGA; breast cancer; HCCS; immune inﬁltration; overall survival; relapse-free survival  \n1. Introduction  \nBreast cancer is the most commonly diagnosed cancer in women globally and remains a major cause of cancerrelated death, despite improvements in early detection and therapy [1] . In 2022, it accounted for an estimated 2.3 mil-  \nlion new cases, representing ~ 11.6% of all cancer diagnoses globally [2] . As one of the most prevalent malign","cbCaivbw4qyFJYqZ","https://ap.wps.com/l/cbCaivbw4qyFJYqZ","pdf",5390517,27,"English","# Background\n# Objective\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is the main objective of this study on HCCS in breast cancer?\",\"answer\":\"To examine HCCS expression profiles, epigenetic regulation, immune interactions, prognostic significance, and molecular networks, focusing on breast cancer and particularly triple-negative breast cancer.\"},{\"question\":\"How was HCCS expression and methylation analyzed in the study?\",\"answer\":\"The study used public datasets and bioinformatics tools to evaluate HCCS expression and promoter methylation patterns, including TCGA, UALCAN, and TNMplot.\"},{\"question\":\"What key findings connect HCCS to breast cancer prognosis and immune infiltration?\",\"answer\":\"HCCS was overexpressed in breast cancer with the strongest increase in TNBC; promoter hypomethylation was associated with higher expression. High HCCS correlated with poorer relapse-free survival and greater immune infiltration across multiple immune cell types.\"}]","HCCS Serves as Potential Prognostic Biomarker and Therapeutic Target in Human Breast Cancer - Research Article | PDF",1790186279,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9a05e666bcb1eedb717e664ac29d8fa.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b7282503d1dd4e8e4feab952a8af018.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf75d507f7434103c66cc4e9b5392d2d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be17a7b4f4fa32e19cd515aca5029e58.webp",980,1306]